Rituximab in ANCA-associated vasculitis: fewer infusions or ultra low-dose maintenance therapy?

被引：7
|
作者：
Moiseev, Sergey V. [1 ]
Bulanov, Nikolai M. [1 ]
Zykova, Anastasiia S. [2 ]
Novikov, Pavel I. [1 ]
机构：
[1] Sechenov First Moscow State Med Univ, Tareev Clin Internal Dis, Moscow 119435, Russia
[2] Lomonosov Moscow State Univ, Fac Med, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷 / 09期
关键词：
D O I：
10.1136/annrheumdis-2018-213873
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E99 / +
页数：2
相关论文
共 50 条
  • [41] Rituximab Immunogenicity in ANCA-associated Vasculitis (RITUXIMAV)
    Springer, Jason
    Funk, Ryan
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [42] Extending the Indications for Rituximab in ANCA-Associated Vasculitis
    Jayne, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (19): : 1839 - 1840
  • [43] Rituximab for ANCA-associated vasculitis: The UK experience
    Jayne, David
    PRESSE MEDICALE, 2013, 42 (04): : 532 - 534
  • [44] Rituximab Induction and Maintenance in ANCA-Associated Vasculitis: State of the Art and Future Perspectives
    Treppo, Elena
    Binutti, Marco
    Agarinis, Roberto
    De Vita, Salvatore
    Quartuccio, Luca
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [45] A Single Center Retrospective Analysis of Efficacy and Safety Between Low-Dose versus High-Dose Rituximab as Remission Induction Therapy with ANCA-Associated Vasculitis
    Hirose, Kei
    Hirata, Manami
    Ueno, Akiko
    Yamamura, Masahiro
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [46] RITUXIMAB AS MAINTENANCE TREATMENT IN ANCA-ASSOCIATED VASCULITIS: SINGLE-CENTRE EXPERIENCE
    Hruskova, Zdenka
    Posova, Helena
    Bednarova, Vladimira
    Jancova, Eva
    Rysava, Romana
    Frausova, Doubravka
    Tesar, Vladimir
    RHEUMATOLOGY, 2017, 56 : 154 - 155
  • [47] Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
    Smith, Rona M.
    Jones, Rachel Bronwen
    Specks, Ulrich
    Bond, Simon
    Nodale, Marianna
    Aljayyousi, Reem
    Andrews, Jacqueline
    Bruchfeld, Annette
    Camilleri, Brian
    Carette, Simon
    Cheung, Chee Kay
    Derebail, Vimal
    Doulton, Tim
    Forbess, Lindsy
    Fujimoto, Shouichi
    Furuta, Shunsuke
    Gewurz-Singer, Ora
    Harper, Lorraine
    Ito-Ihara, Toshiko
    Khalidi, Nader
    Klocke, Rainer
    Koening, Curry
    Komagata, Yoshinori
    Langford, Carol
    Lanyon, Peter
    Luqmani, Raashid Ahmed
    Makino, Hirofumi
    McAlear, Carole
    Monach, Paul
    Moreland, Larry W.
    Mynard, Kim
    Nachman, Patrick
    Pagnoux, Christian
    Pearce, Fiona
    Peh, Chen Au
    Pusey, Charles
    Ranganathan, Dwarakanathan
    Rhee, Rennie L.
    Spiera, Robert
    Sreih, Antoine G.
    Tesar, Vladimir
    Walters, Giles
    Weisman, Michael H.
    Wroe, Caroline
    Merkel, Peter
    Jayne, David
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (09) : 1243 - 1249
  • [48] Safety of Methotrexate and Low-Dose Trimethoprim-Sulfamethoxazole in Patients with ANCA-Associated Vasculitis
    Tamaki, Hiromichi
    Butler, Robert
    Langford, Carol A.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [49] Glucocorticoid dose in ANCA-associated vasculitis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2021, 3 (07): : E479 - E479
  • [50] Retreatment With Rituximab In The Rituximab In ANCA-Associated Vasculitis (RAVE) Trial
    Miloslavsky, Eli
    Specks, Ulrich
    Merkel, Peter A.
    Seo, Philip
    Spiera, Robert F.
    Langford, Carol A.
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    St Clair, E. William
    Tchao, Nadia
    Ding, Linna
    Ikle, David
    Jepson, Brett
    Brunetta, Paul
    Stone, John H.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1190 - S1190
12345